ãã¢ã«ãã³ãã³ãã£ã©ãŒãšã¯äœã§ãã?ãã€ã¯ãããŒããªã³ã°ã泚å°å¯èœãªãã£ã©ãŒãšã©ãéãã®ã§ãã?
ãã¢ã«ãã³ãã³ãã£ã©ãŒ ãã¢ã«ãã³ãã³ã¯ãéã䜿ããã«ç°¡åãã€å®å
šã«ãã¢ã«ãã³é
žãæäžããæ¹æ³ã§ããå§åã§äœåãããããã¯ãç®èã®è¡šé¢ã®äžã«å®å
šã«æ³šå
¥ããã®ã«ååãªåãçã¿åºããŸãã ãã®ããªãŒãã¡ã³ãã¯ãéãæããã客æ§ããŸãã¯åŸæ¥ã®ãã£ã©ãŒè£œåã®é泚å°ãåããããªãã客æ§ã«æé©ã§ããããã«ã䟵襲æ§ãäœãã§ãã ãã¢ã«ãã³ãã³ãã£ã©ãŒãšã¯äœã§ãã? ãã¢ã«ãã³é
žãã³ãã£ã©ãŒã¯ãã»ãããç·ãããªãªãããã©ã€ã³ãªã©ã®é¡ã®çްãç·ãæ»ããã«ããæãããããããã«èšèšãããéã®ãªã泚å°å€ã§ãããããã¯ãåšå²ã®çµç¹ãå·ã€ããããšãªããã¢ã«ãã³é
žãã£ã©ãŒãåäžãªæµãã§ç®èã«æµžéãããã®ã«ååãªå§åãå ããããšã§æ©èœããŸããæ²»çã¯éåžžãçã¿ã䌎ããã«è¿
éã«è¡ãããŸãããã®åŸè
«ãããããçºèµ€ãçŸããããšããããŸãããçç¶ã¯éåžžæ°æé以å
ã«æ²»ãŸããŸãã ãã¢ã«ãã³é
žãã³ã®äœ¿çšã¯ããã®æé ã«éã䜿çšããªããããåŸæ¥ã®å泚å°ãããçã¿ãã¯ããã«å°ãªããšå€ãã®ã¯ã©ã€ã¢ã³ããå ±åããŠããŸãããã ããããã¯äžæçãªè§£æ±ºçãšããŠã®ã¿èæ
®ãããã¹ãã§ãããæé©ãªçµæãç¶æããã«ã¯æ°ãæããšã«ä¿®æ£ãå¿
èŠã«ãªãå Žåãããããšã«æ³šæããŠãã ããã åžå Žã«ã¯ããŸããŸãªãã©ã³ãã®ãã¢ã«ãã³é
žãã³ã販売ãããŠããããã®å質ã¯å€§ããç°ãªãå ŽåããããŸãã FDA ã®æ¿èªãåããä¿¡é Œã§ããäŒæ¥ã«ãã£ãŠè£œé ãããŠãããã®ãããã°ãããã§ãªããã®ããããŸããå®¶åºçšã¢ãã«ã¯èª€äœåãèµ·ãããé广çãŸãã¯å±éºãªçµæã«ã€ãªããå¯èœæ§ãããããŸãã ãã¢ã«ãã³é
žãã³ã¯ãã«ã«ã·ãŠã ããããã·ã«ã¢ãã¿ã€ã (CaHa) ã»ã©é·æçãªè§£æ±ºçã§ã¯ãããŸããããã¢ã«ãã³é
žã¯ãèªç¶ã«åè§£ãããŠäœã«åžåããããŸã§ãããã 6 ïœ 8 é±éããæç¶ããŸããã ãã¢ã«ãã³é
žãã³ã«ã¯ããã£ã©ãŒãäžé©åãªé åã«é
眮ãããªã¹ã¯ã䌎ããŸããããã«ãããçæ³çãšã¯èšããªãçµæãåŸãããå¯èœæ§ããããããã«ã¯è¡ç®¡ã®è©°ãŸããªã©ã®å䜵çãçºçããŠç®ãžã®é
žçŽ ã®æµããæžå°ããæ¥µç«¯ãªå Žåã«ã¯äžæçãªå€±æãåŒãèµ·ããå¯èœæ§ããããŸãã ãã¢ã«ãã³é
žãã³ã¯ä»ã®æ³šå°ã®ããã«ã³ã©ãŒã²ã³ã®çæãåºæ¿ãããè¥ããå埩ããã³ã©ãŒã²ã³ã®çæãšããéèŠãªåŽé¢ãæ¬ ããŠããããããã€ã¯ãããŒããªã³ã°ãªã©ã®æ²»çæ³ãããç®èã®å¥åº·ãžã®æçæ§ãäœããªããŸããããã§ãããããã¯è¿
éãã€é·æçãªçµæãæäŸãããªãããã£ã©ãŒãªã©ã®åŸæ¥ã®ãã£ã©ãŒã®è¿
éãªè§£æ±ºçãæ¢ããŠããå Žåã«ä»£æ¿ãªãã·ã§ã³ãæäŸããå¯èœæ§ããããŸãã ãã¢ã«ãã³ãã³ãã£ã©ãŒã¯ãã€ã¯ãããŒãã«ã泚å°å¯èœãªãã£ã©ãŒãšã©ãéãã®ã§ãã? ãã¢ã«ãã³ãã³ãã£ã©ãŒã¯ãéã®ä»£ããã«ç©ºæ°å§ã䜿çšããŠæ³šå°ãè¡ãç¹ã§åŸæ¥ã®æ³šå°ãšã¯ç°ãªããå ããå§åãå§åãå¶åŸ¡ãããã©ã³ãžã£ãŒããããŸããããããã¯ããã«é£ãããªããçµæãäºæž¬ãã«ãããªããŸããããã«ããããã¯é¡ã®çç®ä¹³é å±€ã«ã®ã¿å°éãããã倧ããªå€åãå ããããšãã§ããŸããã ãããã®ãã³ã«äœ¿çšãããŠãããã¢ã«ãã³é
žã¯äœå
ã§èªç¶ã«çæãããããããã®æ©èœã¯äœå
ã§çæããããã¢ã«ãã³é
žãåæ ããŠããŸãããã¢ã«ãã³é
žã¯æ°ŽååãåŒãä»ããç®è现èã«æœ€ããäžããèŠãç®ããããµã£ãããšè±ãã«ããããšãã§ããŸããããã«ããã®æ¶æ©ç¹æ§ã¯ãäœå
ã®é
µçŽ ã«ããåè§£ãé²ãã®ã«åœ¹ç«ã¡ãŸãããã ãã人éã®äœå
ã§çæããããã®ç©è³ªã®å¯¿åœã¯ããã®ç©è³ªã§äœããããã£ã©ãŒãæ°ãæãå Žåã«ãã£ãŠã¯æ°å¹Žãæ¶æ©ã§ããã®ã«æ¯ã¹ãŠæ¯èŒççãã§ãã ãã£ã©ãŒã®åãåãã«é¢ããŠã¯ãè³æ Œã®ããçŸå®¹æœè¡è
ã®ã¿ãæœè¡ãè¡ãå¿
èŠããããŸãã圌ãã®ã¹ãã«ãšç¥èã¯å®å
šã§å¹æçãªãã£ã©ãŒæ²»çãä¿èšŒããŸããæ³šå°ã®å質ã«é¢ãã FDA åºæºãæºãããŠããªããã¢ã«ãã³ ãã³ãªã©ã®æªæ¿èªã®åšå
·ã䜿çšããŠèªå®
ã§ãã£ã©ãŒã詊ã¿ãããšã¯æ±ºããŠæšå¥šãããŸããã ãã¢ã«ãã³ãã³ã䜿çšããå ŽåãææãæãŸãããªãå¯äœçšãé²ãããã«ãå®ãã¹ãéèŠãªã«ãŒã«ãããã€ããããŸããå¿
ãç¡èç°å¢ã§äœ¿çšããæ±æã«å¯ŸããŠããããäºé²æªçœ®ãè¬ããŠãã ãããåžžã«å
å¡«æžã¿ã®ã¢ã³ãã«ã䜿çšããŠãã ãããèªåã®ãã¢ã«ãã³é
žãããã€ã¹ã«çŽæ¥è¿œå ããªãã§ãã ããã ãã¢ã«ãã³ãã£ã©ãŒã¯åã匷調ããç®çã®ã¿ã«äœ¿çšããããšããåŸãã¹ãéèŠãªã«ãŒã«ã§ããããšã«æ³šæããŠãã ããããã®ä»ã®äœ¿çšã¯å䜵çãåŒãèµ·ããå¯èœæ§ããããããå»çæäŸè
ã®äºåã®çžè«ãšæ¿èªãªãã«äœ¿çšããªãã§ãã ãããããã«ããã®åœ¢åŒã®æ²»çæ³ã¯ããã€ã¯ãããŒãã«ã泚å°å¯èœãªãã£ã©ãŒã«ä»£ãããã®ã§ã¯ãããŸãããã©ã¡ããããŠã³ã¿ã€ã ãå¿
èŠãšããããããæ»ããã«ããŠå¹Žéœ¢ãæããããªãèŠãç®ã«ããã®ã«åœ¹ç«ã¡ãŸãããããè¥è¿ãã®æè¯ã®æ¹æ³ã§ãã ãã¢ã«ãã³ãã³ãã£ã©ãŒã®å©ç¹ã¯äœã§ãã? ãã¢ã«ãã³é
žãã³ãã£ã©ãŒã¯ãããªã¥ãŒã ã远å ããå°ããããããä¿®æ£ããèã®å
šäœçãªå€èŠ³ãæ¹åããããã®å¹æçã§é䟵襲çãªãœãªã¥ãŒã·ã§ã³ãæäŸããŸãããã¢ã«ãã³é
žãã³ã¯ãã³ã¹ããåæžãããå¯äœçšããªããããç®èå
å¡«å€ããããã¯ã¹æ³šå°ã®çæ³çãªä»£æ¿åã§ãã ãã¢ã«ãã³ãã³ã¯ãéã§ã¯ãªã空æ°å§ã䜿çšããŠãã¢ã«ãã³é
žãç®èã«æ³šå
¥ãããããä»ã®ãã£ã©ãŒæ³šå°ãšã¯ç°ãªããŸããå§åã¯ç¥çµãè¡ç®¡ã«åœ±é¿ãäžããããšãªã衚ç®ã®ä¹³é å±€ã«èªå°ããããããææèã®æ£è
ãæ²»çããéã«å®å
šã«äœ¿çšã§ããããã€ã¹ãšãªããŸãã...
éåœã®ãã£ã©ãŒã®å€æ®µã¯ãããã§ãã?ãããŠã©ããæè¯ã®ãã£ã©ãŒã§ãã?
éåœã¯çŸå®¹æŽåœ¢ãšçŸå®¹æ³šå°ç£æ¥ã§æåã§ããé«åºŠãªãã¢ã«ãã³é
žããŒããã£ã©ãŒè£œé æè¡ãæããŠãããäŸ¡æ Œç«¶äºåã®ããé«å質ã®HAãã£ã©ãŒãçç£ããŠããŸãã Yvoire ãš Elravie ã¯ã泚å°ããã»ã¹ã®å®å®æ§ãé«ããã·ãªã³ãžèšèšã§ç¥ããã KFDA æ¿èªã®ãã£ã©ãŒ ãã©ã³ãã§ãã Teosyal ã¯ãã¢ã¬ã«ã®ãŒåå¿ãæããããã«ã¿ã³ãã¯è³ªäžçŽç©ãåæžãã人æ°ã®ãã£ã©ãŒ ãã©ã³ãã§ããæéãã§ã€ã·ã£ã«ãã£ã©ãŒã®è³Œå
¥ãèšç»ããŠããå Žåã¯ãé©åãªãã©ã³ããšæè¡ãéžæããããšãéèŠã§ãããã®ããªãŒãã¡ã³ãã¯ãèªç¶ãªèŠãç®ã®ãã§ã€ã¹ãªãããå®çŸããèãè¥è¿ãããã®ã«åœ¹ç«ã¡ãŸããã»ãããç·ãåãé€ããåãçŸãããã錻ã®åœ¢ãæ¹åããããã«ã䜿çšã§ããŸãããããã®ç®èå
å¡«å€ã¯ã现ãéã®æ³šå°åšã䜿çšããŠæšçé åã«æ³šå
¥ãããŸããæé ã¯è¿
éã§çã¿ã¯ãããŸããã ããŸããŸãªçš®é¡ã®ãã£ã©ãŒãå©çšå¯èœã§ãããæãåªããŠããã®ã¯ãæç¶æéãé·ããèªç¶ãªä»äžããããããããã£ã©ãŒã§ããæãäžè¬çãªãã£ã©ãŒã«ã¯ããã¢ã«ãã³é
žãšããª-L-ä¹³é
ž (PLLA) ãå«ãŸããŸãããããã®ãã£ã©ãŒã¯æç¶æ§ããããã³ã©ãŒã²ã³ã®æé·ãä¿é²ããèãæ»ããã§ããªããã«ããŸããçŸå®¹å¹æãé«ããããã«ãå®å
šã«äœ¿çšã§ããŸãããã§ã€ã¹ãã£ã©ãŒãéžã¶ãšãã¯ãäºç®ãšæãçµæãèæ
®ããããšãéèŠã§ããããšãã°ããªãããã£ã©ãŒã®äŸ¡æ Œã¯éåžž 2,000 ãã«ãã 4,000 ãã«ã§ããéžæããæè¡ã«å¿ããŠãçµæã¯æå€§ 5 幎éæç¶ããŸãããã¢ã«ãã³é
žç®èå
å¡«å€ã«ã¯ãã¢ã¡ãªã«ãéåœã®ãã©ã³ããªã©ãããã€ãã®éžæè¢ããããŸããã¢ã¡ãªã«è£œåã¯äžè¬çã«é«äŸ¡ã§ãããéåœè£œåã¯ããæé ãªäŸ¡æ Œã§ããäŸ¡æ Œã®éãã¯ãéåœè£œãã£ã©ãŒãã¯ãªããã¯ã§ããåºã䜿çšãããŠããããã®çµæãäŸ¡æ Œãå®ããªã£ãŠããããã§ãã éåœã§æã人æ°ã®ãããã¢ã«ãã³é
žãã£ã©ãŒãã©ã³ãã¯Revolaxã§ãçºå£²ãããŠ6幎ã«ãªããŸãããã®ãã©ã³ãã¯ããã®èä¹
æ§ãšé«ãç²åºŠã®ãããã§ãçŸå®¹ã«äººæ°ã®ãã©ã³ããšãªã£ãŠããŸãããã®ãã©ã³ãã¯FDAããã³KFDAã®æ¿èªãåããŠãããå®å
šã«äœ¿çšã§ããŸããå瀟ã§ã¯ç¡æçžè«ãè¡ã£ãŠããã®ã§ãæç¶ãã«æ
£ããŠããªã人ã§ãå®å¿ã§ãããã¢ã«ãã³é
žãã£ã©ãŒã®ãã 1 ã€ã®éžæè¢ã¯ãããŸããŸãªåæ°žä¹
ãã£ã©ãŒãæäŸãã Remedium ã§ãããã®äŒç€Ÿã¯ããã¢ã«ãã³é
žéãç¹èš±ååŸæžã¿ã®åŸ®ç²åã§æ¶æ©ããããšã«ããé«ç²åºŠã®ã²ã«ãäœæããããšãå°éãšããŠããŸããåŸããã補åã¯èä¹
æ§ããããæåœ¢æ§ãåªããŠããŸããéåœã§äººæ°ã®ããä»ã®ãã¢ã«ãã³é
žãã£ã©ãŒ ãã©ã³ãã«ã¯ãã€ãã¯ãŒã«ããã¥ãŒã©ãã¹ããšã©ãŽã£ãªã©ããããŸãããããã®ãã§ã€ã¹ãã£ã©ãŒã¯ãèã«ãµã£ããæãäžããããªã¥ãŒã ãããããããã«èšèšãããŠããŸããéåžžãé ¬ããããé¡ã®ã©ã€ã³ã®é åã«äœ¿çšããããšããå§ãããŸããæšå¥šäºé
éåœã¯ããªãããã£ã©ãŒãã¯ãããšããå€ãã®çŸå®¹å¹æã®ããæ²»çæ³ã§ç¥ãããŠããŸãããããã¯åãçŸããããããè±ãã§é
åçãªãã®ã«ããã®ã«æé©ã§ãããããã¯ãããæ»ããã«ããç·ãæžããã®ã«ã广çã§ããããã¯æ°åã§å®äºããç°¡åãªæ²»çæ³ã§ã蚺å¯å®€ã§ããã«è¡ãããšãã§ããŸããæœè¡åŸã¯å€å°ã®è
«ããåºãå ŽåããããŸãããããã«ä»äºãæ¥åžžç掻ã«åŸ©åž°ããŠããã ããŸããåžå Žã«ã¯ããã€ãã®ç°ãªãçš®é¡ã®ãã¢ã«ãã³é
žãã§ã€ã¹ãã£ã©ãŒãããããããã¯ãã¹ãŠç°ãªãåããããŸããåæ°žä¹
çãªãã®ããããŸãã®ã§ãæ°å¹Žé䜿çšã§ãããã®ããããŸãããããã¯ã幎霢ãšãšãã«å€±ãããã³ã©ãŒã²ã³ã埩掻ãããã®ã«ãæé©ã§ããæã人æ°ã®ãããã¢ã«ãã³é
žãã£ã©ãŒã«ã¯ãJuvedermãRestylaneãRevolax ãªã©ããããŸãããããã¯ãã¹ãŠãããè¥ã
ããèŠããããæ£è
ã«ãšã£ãŠã¯è¯ãéžæã§ããã4ïœ6é±éããšã®ãã©ããŒã¢ããæ²»çãå¿
èŠã§ãã ãã 1...
ããããã£ã©ãŒã¯ãããã®ããŒã¿ã軜æžããŸã
è¡é¢ç¯ã®ããŒã¿ãç®ç«ããªããããå Žåã¯ãããã€ãã®ãªãã·ã§ã³ããããŸããæè¡ãåããããšããè¡é¢ç¯ãã£ã©ãŒãªã©ã®éå€ç§çä»£æ¿ææ®µã«é Œãããšãã§ããŸãã å¢å€§æ²»çãšããŠãç¥ãããããããã£ã©ãŒã¯ããããã®èŒªéãæ¹åããããåŒãç· ãŸã£ãå€èгãäžããããã«èšèšãããŠããŸããã³ã«ãã³ã¹ããã€ããå€è¡å°æ¿è¡æŒ¿ (PRP)ãèèªç§»æ€ãªã©ãããã€ãã®æè¡ããããŸãã ã³ã«ãã³ã¹ããã€ã ã³ã«ãã³ã¹ããã€ãã¯ãããŸããŸãªçç¶ã®æ²»çã«äœ¿çšãããäººå·¥ã®æççè¬ã§ãããããã¯ãççã軜æžããå
ç«ã·ã¹ãã ãæå¶ããçã¿ãé²ãããšã«ãã£ãŠæ©èœããŸãã ãããã®è¬ã¯ãé¢ç¯ãªãŠããã忝ãå€åœ¢æ§é¢ç¯çãªã©ã®æ
¢æ§ççæ§çŸæ£ã®æ²»çã«ãã䜿çšãããŸãããŸããã¢ã¬ã«ã®ãŒãã¢ãžãœã³ç
ãªã©ã®èªå·±å
ç«çŸæ£ãç§»æ€æçµ¶åå¿ã«ã圹ç«ã¡ãŸãã ãããããããã®è¬ãé·æé䜿çšãããšã骚ç²é¬çãšåŒã°ãã骚ãããããªãå¯èœæ§ããããŸãã骚ãä¿è·ããããã«ã«ã«ã·ãŠã ãšãã¿ãã³ D ã®ãµããªã¡ã³ããæåããããšã«ã€ããŠå»åž«ã«çžè«ããŠãã ããã çã¿ã軜æžããããã®ã¹ããã€ãé¢ç¯å
泚å°ã¯ãå€åœ¢æ§è¡é¢ç¯çãŸãã¯èé¢ç¯çã®æ£è
ã«ããè¡ãããŸãããããã2022幎6æã«çºè¡šãããå€§èŠæš¡ãªç ç©¶ã§ã¯ãé¢ç¯çœ®æè¡ã®å¿
èŠæ§ãé«ãŸãå¯èœæ§ãããããšã倿ããŸããã å€è¡å°æ¿è¡æŒ¿ è¡æ¶²ãæ¿çž®ããå€è¡å°æ¿è¡æŒ¿ (PRP) ã¯ãçã¿ã䌎ãçç¶ãç·©åããæ²»çãä¿é²ããæ°ããè¡é¢ç¯æ²»çæ³ã§ãããŸããé¢ç¯çœ®ææè¡ã®å¿
èŠæ§ãé
ããå¯èœæ§ããããŸãã PRP ã¯ãè¡æ¶²ãµã³ãã«ãæ¡åããé å¿å颿©ã§å転ãããŠè¡å°æ¿ãæ®ãã®è¡çããåé¢ããããšã«ãã£ãŠäœãããŸããããã«ãããPRP ã«ã¯éåžžã®è¡æ¶²ããã 5 ïœ 10 åé«ãè¡å°æ¿æ¿åºŠãäžããããŸãã æªæã®éãè¡å°æ¿ã¯è¡æ¶²ã®ååºãå©ããæé·å åãæå·éšäœã«éã³èŸŒãã§æ²»çãæ©ãããšããéèŠãªåœ¹å²ãæãããŸãã PRP ã¯æå·çµç¹ã«çŽæ¥æ³šå°ãããçèãé±åž¯ãè
±ã®æå·ãå«ãããã€ãã®æŽåœ¢å€ç§ççç¶ã®æ²»çã«äœ¿çšã§ããŸããé¢ç¯ç;ãããŠéªšæã ããç ç©¶ã§ã¯ãã³ã«ãã³ã¹ããã€ãæ²»çã«åå¿ããªãã£ãæ
¢æ§äºåè©æ£è
29åã«ãããŠãä¿åçæ³ãšæ¯èŒããŠPRPååæ³šå°ã«ããçã¿ãšæ©èœã¹ã³ã¢ãæ¹åãããããšãããããŸãããããã«ããJournal of Arthroscope and Associated Surgeryãã«æ²èŒãããç ç©¶ã§ã¯ãPRPãšãã¢ã«ãã³é
žæ³šå°ã®äœµçšãå€åœ¢æ§è¡é¢ç¯çã®æ£è
ã«å¹æçã§ãããšå ±åããŸããã...
ã¬ãããã» ããŒãµ ãã£ã©ãŒ
人æ°ã®ãã¢ã«ãã³é
žãã£ã©ãŒã§ããããŒãµã¯ãé¡ã®èåã®å
åãæ¹åããã女æ§ãšç·æ§ã®éã§äººæ°ããããŸããæ³šå
¥ãç°¡åãªã ãã§ãªããä»ã®å€ãã®ç®èå
å¡«å€ãããå¿«é©ã§ãã ãã®ãã¢ã«ãã³é
žããŒã¹ã®ãã£ã©ãŒã¯ãåã®ãµã€ãºã倧ããããå£ã®åšãã®å°ããããããæ»ããã«ããã®ã«æé©ã§ãããããé ¬ããµã£ãããããã»ãããç·ãæ¹åããé¡ã®ããªã¥ãŒã ãåãæ»ãã®ã«ã广çã§ãã ãŽã¡ãŒãµãšã¯äœã§ããïŒ åã«ããªã¥ãŒã ãå ããŠèŒªéãã¯ã£ããããããå Žåã¯ãRevanesse Versa ãã£ã©ãŒãæé©ãªããªãŒãã¡ã³ãã§ãããã®æ³šå°å¯èœãªç®èå
å¡«å€ã¯ãã¢ã«ãã³é
žã§æ§æãããŠãããåãé¡ã®åšå²ã®å°ãããããããã®ä»ã®èåã®å
åãæ¹åããããã«äœ¿çšã§ããŸãã ãã®ãã£ã©ãŒã«å«ãŸãããã¢ã«ãã³é
žã¯ç®èã«æ°ŽåãåŒãå¯ããæãããèªç¶ãªããªã¥ãŒã ãäžããç®èã®ããã¿ãããã軜æžããŸãããŸããé¡ãæ»ããã«ããŠåœ¢ãæŽããèªç¶ã§ãããããªå€èгãå®çŸããŸãã ãŸããVersa ã¯ååéãé«ããããäœå
ã§ãããã£ãããšåè§£ãããçµæãããé·ãæç¶ããŸããããã«ã现ãã²ãŒãžã®éã䜿çšããŠæ³šå°ã§ããããã«èšèšãããŠãããThixofix æ¶æ©æè¡ãåããŠãããããæ³šå°äžã®ç²åºŠãäœããªããå§åãè§£é€ããããšéåžžã®ç¶æ
ã«æ»ããŸããããã¯æ³šå°åŸã®è
«ããæå°éã«æããã®ã«åœ¹ç«ã€ããããã£ã©ãŒæ²»çãæå€§éã«æŽ»çšããã人ã«ãšã£ãŠã¯ããè¯ãéžæã§ãã Versaã¯ãã¢ã«ãã³é
žãã£ã©ãŒã§ã ãã¢ã«ãã³é
žã¯ãæãããããªã¥ãŒã ã®ããèã«äžå¯æ¬ ãªå€©ç¶ç©è³ªã§ããæ°Žåãç®èã«çµåãããèªç¶ãªæ§é ãç¶æããã®ã«åœ¹ç«ã¡ãŸãã幎霢ãéãããšãã¢ã«ãã³é
žã®çæãé
ããªããé¡ã®ããªã¥ãŒã ã®æžå°ãã·ã¯ã®åå ãšãªããŸãã 幞ããªããšã«ãJuvedermãRestylaneãSculptraãRadiesse ãªã©ããã¢ã«ãã³é
žãå«ãããŸããŸãªç®èå
å¡«å€ããããŸãããããã®æ³šå°å¯èœãªè£œåã¯ãããããèåã®ç¹å®ã®å
åãæ²»çããããã«é
åãããŠããŸãã Versa ã¯ã2017 幎㫠FDA ã®æ¿èªãåããæ¯èŒçæ°ãããã¢ã«ãã³é
žãã£ã©ãŒã§ããç¹çްã§èªç¶ãªä»äžãããå®çŸããçæ³çãªãã£ã©ãŒã§ããå°ããªç圢ã®ãã¢ã«ãã³é
žç²åã䜿çšããŠãããããæ³šå
¥ãã¹ã ãŒãºã«ãªããä»ã®ãã¢ã«ãã³é
žãã£ã©ãŒãããèšæœ€ã 24% å°ãªããªããŸãã ããŒãµã¯å®å
šã§ã Versa ã¯ãé¡ã®ããŸããŸãªéšåã«äœ¿çšã§ããå®å
šã§å¹æçãªãã£ã©ãŒã§ãããããæ»ããã«ããåãé ¬ãé¡ã®ã©ã€ã³ã«ããªã¥ãŒã ãå ããããšãã§ããŸãã ä»ã®ãã¢ã«ãã³é
žããŒã¹ã®ç®èå
å¡«å€ãšäŒŒãŠããŸãããVersa ã®çç¶ç²åã«ããããã®ããªãŒãã¡ã³ãã¯ç¹ã«å¹æçã«èã«æº¶ã蟌ã¿ãŸãããããã®ç²åã¯ä»ã® HA ããŒã¹ã®ãã£ã©ãŒãããé·æã¡ããåŸåããããåŠçåŸã®èšæœ€ãããã»ã©å€§ãããããŸããã ãã®ãããVersa ã¯ãJuvederm...
ãããã£ã©ãŒããã5
ãããã£ã©ãŒã¯ãç®èã®åŒ±ã£ãéšåã®ããªãšåœ¢ç¶ãå埩ããçŸå®¹åŠçœ®ã®äžçš®ã§ããããã¯ãé¡ã®ç¹å®ã®é åã«å°éã®ãã£ã©ãŒã泚å
¥ããããšã«ãã£ãŠè¡ãããŸãã ãããã£ã©ãŒã«ã¯ããŸããŸãªçš®é¡ãããããããããç°ãªãç®èã®åé¡ãæ²»çããããã«èšèšãããŠããŸãããããã£ã©ãŒã®äžã«ã¯ãäž»ã«å³å¹æ§ãç®çãšããŠäœããããã®ããããŸãããé·æçãªå¹æããããããã®ããããŸãã Boyd's ãªã³ã¯ã« ãã£ã©ãŒ ã¡ã€ã¯ã¢ãã ããŒã¹ & ã¹ã ãŒã¶ãŒ èãæ»ããã«ãããªã³ã¯ã«ãã£ã©ãŒããæ¢ããªããBoyd's Wrinkle Filler Makeup Base & Smoother ããŽã£ããã®è£œåãããããŸãããã·ã¯ãåããŠãã¬ã³ãããããªããŒã®çµã¿åãããå«ãŸããŠãããæ»ããã§è¥ã
ããå€èгãå®çŸããŸãã ãã®ã·ã¯åãå€ã«ã¯ãã¢ã«ãã³é
žãå«ãŸããŠãããæ°Žåã¬ãã«ãé«ããèã®ãã¡ãŒãžã®ä¿®åŸ©ã«åœ¹ç«ã¡ãŸããæé
žåç©è³ªã¯ãèãžã®ããªãŒã©ãžã«ã«ã«ãããã¡ãŒãžã軜æžããŸãã ããã«ããã®ãªã³ã¯ã«ãã£ã©ãŒã¯ãã€ã€ã¢ã³ãããŠããŒã䜿çšããŠãããå
ãåå°ããŠã·ã¯ãé²ããŸããããã«ããããããã¯å®è³ªçã«èŠããªããªããé¡ã«çŸããã®ãé²ããŸãã ãã¬ã¹ & ãªã㌠ã¢ã³ããŒã¢ã€ ã¯ãªãŒã Terez & Honor ã¢ã³ããŒã¢ã€ ã¯ãªãŒã ã¯ãç®ã®åšãã®å°ããããããæžããã®ã«åœ¹ç«ã€ãããã£ã©ãŒã§ããããã¿ãã¯ãã軜æžããã®ã«ã圹ç«ã¡ãŸãã å®å
šã§èã«åªããåŠæ¹ã§ãé·æçã«ã¯ãããã®åå ã«ãªããŸãããã¡ã³ããã³ã¹ãæé€ãç°¡åã§ãã...
ããè¥ã ããå€èгã®ããã®ã¢ã€ãã£ã©ãŒ
ããªãã®ç®ã¯ä»ã®äººãæåã«ç®ã«ãããã®ã§ãããã¯ããããŒãã ç®ãç®ã®äžã®ããã¿ãããããããšãç²ããå°è±¡ãäžããè¿ã¥ããããå°è±¡ãäžããããšããããŸãã ã¢ã€ãã£ã©ãŒïŒããŒãã«ãã£ã©ãŒïŒã¯ãç®èã«ããªã¥ãŒã ãšåŒŸåæ§ãäžããæ³šå°å¯èœãªã²ã«ç¶ã®æº¶æ¶²ã§ãããŸããã³ã©ãŒã²ã³ã®çæãä¿é²ããé¡ã«è¥ã
ããèŒããäžããŸãã 1. ã¬ã¹ãã¬ã³Â® Restylane® ã¯ãäœå
ã«ååšãã倩ç¶å€ç³é¡ã§ãããã¢ã«ãã³é
ž (HA) ãå«ãå
å¡«å€ã§ãããã®éæãªãžã§ã«ã¯éåžžã«æãããããªãããªãã¯ã¹ãã£ãŒãæã¡ãå°ãããã·ã¯ã軜æžãã广ãéåžžã«é«ãã§ãã ãŸããåã®ã©ã€ã³ãæ»ããã«ãããã®åœ¢ã匷調ããããšã§ãåã«ããªã¥ãŒã ãå ããããšãã§ããŸãã錻ããå£è§ãŸã§ç¶ã瞊ã®ç·ã§ããã»ãããç·ã®ããæ£è
ã«é©ããŠããŸãã HA ããŒã¹ã®ç®èå
å¡«å€ã®ãã 1 ã€ã®å€§ããªå©ç¹ã¯ãã¢ã¬ã«ã®ãŒåå¿ãåŒãèµ·ããã«ããããšã§ãããããã®è£œåã¯ã泚å°éšäœã®åšå²ã®ãããè
«ãã軜æžããã®ã«åœ¹ç«ã€ã¹ããã€ã ã¯ãªãŒã ãšçµã¿åãããŠäœ¿çšââãããããšããããããŸãã ç®ã®è¥è¿ãã« Restylane ã䜿çšãããšãçã¿ãããŠã³ã¿ã€ã ã䌎ãããšãªããã¯ãã軜æžããç®ã®äžã®ããŒã¿ã軜æžããããšãã§ããŸãããããã®é åãé€å»ãããããå€ç§çä»å
¥ã®æºåãã§ããŠããªãæ£è
ã«ãšã£ãŠãããã¯åªããä»£æ¿ææ®µã§ãã 2. ãžã¥ãããŒã ® Juvederm® ã¯ãäœå
ã«å€©ç¶ã«ååšããç©è³ªã§ãããã¢ã«ãã³é
žã§äœãããçç®å
å¡«å€ã§ããšã©ã¹ãã³ãã³ã©ãŒã²ã³ãšã®çµåãå©ããèã«å¿
é ã®æ é€çŽ ãšåŒŸåæ§ãäžããŸããããã«ãããJuvederm ã¯ãæå€§ 9 ïœ 18 ãæéæç¶ããèªç¶ãªå€èгã®çµæãç¬æã«äœãåºãããšãã§ããŸãã ãžã¥ãããŒã ãé¡ã«æ³šå°ãããšã倱ãããããªã¥ãŒã ãå埩ããç¹ã«å£ã®éšåã®å°ãããã·ã¯ãæ¹åãããŸãããŸããèã«æœ€ããäžããæ»ããã§è¥ã
ããèŒããäžããŸãã æ²»çäžã®çã¿ã軜æžããããã«ããžã¥ãããŒã 泚å°ã«ã¯å°éã®ãªãã«ã€ã³ã泚å
¥ãããŸãããã®æ²»çã¯ã»ãŒãã¹ãŠã®äººã«ãšã£ãŠå®å
šã§å¹æçã§ãã Juvederm ã¯ãåžå Žã§å
¥æå¯èœãªæãäžè¬çãªç®èå
å¡«å€ã®...
éåœã®ãã£ã©ãŒ
éåœã®ãã£ã©ãŒã¯ãé¡ãé¡ãé ¬ããããã¿ã®ããã®äžã®çèãæãããããæ³šå°å€ã§ããããªã¥ãŒã ã¢ãããšããŠãæ©èœããŸãã éåœã§ã¯ãJuvederm Ultra ã Restylane ãªã©ãããã€ãã®ãã¢ã«ãã³é
žãã£ã©ãŒãå
¥æå¯èœã§ãããã®ä»ã®äººæ°ã®ããéåœã® HA ãã£ã©ãŒã«ã¯ãã€ãã¯ãŒã«ããšã©ãŽã£ãŒãªã©ããããŸãã 1. ãªããŒã·ãã« ãã£ã©ãŒã¯ããããç·ããããåãé€ãåªããæ¹æ³ã§ããé¡ã®ããªã¥ãŒã ãåãæ»ãã®ã«ã广çã§ãã éåœã§ã¯ããŸããŸãªãã£ã©ãŒãã©ã³ãããããããããŸãããããã«ã¯èŒžå
¥ãã©ã³ããšåœå
ãã©ã³ããå«ãŸããŸãã ãã£ã©ãŒãéžæããéã«èæ
®ãã¹ãäž»ãªèŠçŽ ã® 1 ã€ã¯å®å
šæ§ã§ããäžéšã®ãã£ã©ãŒã¯ãã¢ã¬ã«ã®ãŒåå¿ãè
«ãããããåŒãèµ·ããå¯èœæ§ããããŸãã ãã 1 ã€ã®èæ
®äºé
ã¯ããã£ã©ãŒãã©ããããã®æéæç¶ãããã§ãããã£ã©ãŒã«ãã£ãŠã¯äœå¹Žã䜿çšã§ãããã®ããããŸãã éåœè£œãã£ã©ãŒã¯éåžžå®å
šã§ãããããããã®ãã£ã©ãŒã«é¢é£ããå
·äœçãªãªã¹ã¯ã«ã€ããŠå»åž«ã«çžè«ããããšãéèŠã§ããããªãã®èã¿ã€ããçŸçç®æšã«æé©ãªãã£ã©ãŒãéžæãããæäŒããããããŸãã 2. é«å質 éåœã§ç®èå
å¡«å€ãå
¥æãããå Žåã¯ãé«å質ã®è£œåãéžæããå¿
èŠããããŸããããŸããŸãªãã©ã³ãããããèªåã®ããŒãºã«åã£ããã®ãéžæããå¿
èŠããããŸãã ããªãã®ç®æšãåãçŸããããããã»ãããç·ãæ¹åãããããããšã§ããå Žåã¯ããããã PMMA ãã€ã¯ãã¹ãã£ã¢ãšãã¢ã«ãã³é
žãæ¢ããããªãã§ãããããããã¯ãã¹ãŠFDAã®æ¿èªãåããŠãããããŸãæ©èœããŸãã éåœè£œãã£ã©ãŒã¯ãã»ãããç·ãå°ããã軜æžãããå Žåãé ¬ãåã匷調ãããå Žåãæè¡ãªãã§éŒ»ãé«ãããã®ã«é©ããéžæè¢ã§ãããããã®ãã£ã©ãŒã¯æåœ¢ãç°¡åã§ãåªããããªã¥ãŒã ãæã¡ãæé· 18 ãææç¶ããŸãã 3. æé ãªäŸ¡æ Œ...
é¡ã®ããã¿ããžã§ãŒãã£ã©ãŒã§ä¿®æ£ãã
é¡ã®ããã¿ããããæè¡ããã«æ²»ãããå Žåã¯ãé¡å
å¡«å€ã圹ã«ç«ã¡ãŸãããã®æ²»çã§ã¯ãç®èå
å¡«å€ã䜿çšããŠé¡ã®åœ¢ç¶ã埮åŠã«å€åãããé¡å
šäœã®å€èгã«é¡èãªéããçã¿åºãããšãã§ããŸãã ã«ãŠã³ã»ãªã³ã°äžã«ãçç·Žããæ³šå°åšãããªãã®ããŒãºãšç®æšãè©äŸ¡ããŸãããã®åŸãã客æ§åºæã®ç¶æ³ã«æé©ãªåŠæ¹ãæšå¥šããŸãã åãäžãã£ãé¡ å¹Žéœ¢ãéããã«ã€ããŠãé¡ã®ããã¿ã¯ããäžè¬çã«ãªããŸããã幞ããªããšã«ãé¡ã®ããã¿ã軜æžãŸãã¯äºé²ããããã«å©çšã§ããæ²»çãªãã·ã§ã³ãæ°å€ããããŸãã é¡ã®ããã¿ã«ã¯ãäœéã®å¢æžãæ¥å
ãžã®æé²ãå«ç
ãªã©ãããŸããŸãªèŠå ãèããããŸããããããããã®çºçãé²ãæã广çãªæ¹æ³ã¯ãå«ç
ãæ¥å
ã«ãããã¡ãŒãžãé¿ããããšã§ãã é¡ã®ããã¿ã®ããäžã€ã®åå ã¯ãäžé©åãªã¹ãã³ã±ã¢ç¿æ
£ã§ããæ é€äŸ¡ã®é«ãã¹ãã³ã±ã¢è£œåã宿çã«äœ¿çšããæé
žåç©è³ªãæççç©è³ªããã¢ã«ãã³é
žãã³ã©ãŒã²ã³ãè±å¯ãªé£äºãæåãããšãèã®åŒŸåæ§ãåäžããé¡ã®ããã¿ãé²ãããšãã§ããŸãã ãããã®å¯Ÿçã«å ããŠãé¡ã®ããã¿ã軜æžããããã«äœ¿çšã§ããå€ç§çåŠçœ®ããããŸãããããã¯ããã¯ãªãããšåŒã°ããå€ãã®å ŽåçŸå®¹å€ç§å°éå»ã«ãã£ãŠè¡ãããŸããéŠã®åŽé¢ã®åšããåéããŠãèèªã®äœçœ®ã倿ŽããçèãåŒãç· ããé¡ã®èŒªéãæŽããããšãå«ãŸããŸãããããã®æè¡ã¯é¡ã®ç®èãäœå¹Žãåãé€ãã®ã«éåžžã«å¹æçã§ãããé倧ãªãªã¹ã¯ããããå䜵çãåŒãèµ·ããå¯èœæ§ããããŸãã é¡ãã£ã©ãŒ ãã³ãã£ã©ãŒã¯ãããã¯ã£ãããšãã圫å»çãªé¡ã®ã©ã€ã³ãå®çŸããããšé¡ããããã幎霢ã®å¥³æ§ãšç·æ§ã«äººæ°ã®æ²»çæ³ã§ãããŸããããªã¥ãŒã ãå ããŠé察称ãªé¡ã®åœ¢ãæ¹åããããé床ã«éãã£ããè§åŒµã£ãé¡ã®ã©ã€ã³ãåããããããããã«ã䜿çšãããŸãã ãã£ããããããã¯çŸããé¡ã®éµã§ããããããããã匱ããªãã®ã¯ãå 霢ãäœéå¢å ããŸãã¯ãã®éšåã®ç®èã®ããã¿ãåŒãèµ·ãããã®ä»ã®èŠå ã«ãã£ãŠåŒãèµ·ããããå¯èœæ§ããããŸãã 幞ããªããšã«ããžã§ãŒã«ãã£ã©ãŒã§ä¿®æ£ã§ããŸãããã®éå€ç§çæè¡ã«ã¯ãé¡ãšäžé¡ã®èŒªéã«ãã¢ã«ãã³é
žã²ã«ã泚å
¥ããããšãå«ãŸããŠãããããã«ããçµç¹ãæã¡äžããŠå®¹ç©ãå€ããé¡ã®ããã¿ã®å€èŠ³ãæ¹åããããšãã§ããŸãã é¡ãã£ã©ãŒæ²»çãåããåã«ãæ
åœè
ãããªãã®é¡ãæ€æ»ããç®æšã«ã€ããŠè©±ãåããŸããããã¯ãããªãã«ãšã£ãŠæé©ãªãã£ã©ãŒã®çš®é¡ãšéãæ³šå
¥ã®æ·±ããšäœçœ®ã決å®ããã®ã«åœ¹ç«ã¡ãŸãã é©åºŠãªé¡ 軜床ã®é¡ã®å Žåã¯ãé¡å
å¡«æ²»çãæ€èšãããšããã§ããããããã¯ãé¡ã®ã©ã€ã³ãæ»ããã«ããŠèŒªéãæŽãããã圫ãã®æ·±ããããã£ãŒã«ãå®çŸã§ãããããç·æ§ãšå¥³æ§ã®äž¡æ¹ã«äººæ°ã®ãªãã·ã§ã³ã§ãã ãã®æ²»çã¯ãå»åŠçã«éçºãããæº¶æ¶²ã现ãéã§ç®äžã«æ³šå°ããããšã§è¡ãããŸããé¡ã埮åŠã«æ»ããã«ãã茪éãæŽãã調åãæŽããé¡ç«ã¡ãéç«ãããã®ã«åœ¹ç«ã¡ãŸãã ãããã¯ãé¡ã®å€èŠ³ãæ¹åããããã«ãSculptra(tm) ãŸãã¯ã¹ã¬ãã ãªããã䜿çšããããšãã§ããŸãããŸãããã®éšåã®ã³ã©ãŒã²ã³ãåºæ¿ããã®ã«ã圹ç«ã€ãããäžçšåºŠã®é¡ãæ²»çããããã®åªãã代æ¿åãšãªããŸãã é¡ã¯èåã®æãäžè¬çãªå
åã® 1 ã€ã§ãããæ¥å
ã«ãããã¡ãŒãžãå«ç
ãéºäŒãé£äºãçæŽ»ç¿æ
£ã«ãã£ãŠåŒãèµ·ããããå¯èœæ§ããããŸããããããé²ãæåã®æ¹æ³ã¯ãå¥åº·çãªé£äºãç¶æãã宿çã«éåããæ¯æ¥ã®æ¥çŒãæ¢ãã§æ¥å
ããèãå®ãããšã§ãã ã¢ãã¬ãŒããã©ã¹ãžã§ãŒã« äžçšåºŠã®ãã©ã¹é¡ã¯è»œåºŠã®é¡ãããé¡èã§ãããé¡å
å¡«å€ã§æ²»çã§ããŸãïŒãã®æ²»çæ³ã«ã€ããŠã®è©³çްã¯ãç§ã®èšäºã§è©³ãã説æããŠããŸãïŒãéåžžãæ£è
ã¯åºæ¬çã« 4 ïœ 8 æ¬ã®æ³šå°åšãå¿
èŠãšããããã 2 ïœ 9...
ãã§ã€ã¹ãã£ã©ãŒã¯æ°žä¹ çãªãã®ã§ããïŒ
ãã§ã€ã¹ãã£ã©ãŒãç®èã«æ³šå
¥ããŠããããæ»ããã«ããããªã¥ãŒã ãå ããŸãããã®æ²»çã¯ãäžæçãã€å¯éçãªäœäŸµè¥²åŠçœ®ã§ãã ã»ãšãã©ã®ãã£ã©ãŒã¯ãã¢ã«ãã³é
žããŒã¹ã§ãããæéã®çµéãšãšãã«åŸã
ã«æ¶ããŠãããããæ²»çãç¶ç¶ãããã©ãããæ±ºå®ã§ããŸããããããç¹ã«é¡ã®ããªã¥ãŒã ã倧å¹
ã«æžå°ããããåçãªçµæãæãã§ããå Žåã«ã¯ãæ°žä¹
çãªãã£ã©ãŒãå¥œãæ£è
ãããŸãã æ°žä¹
çãªãã§ã€ã¹ãã£ã©ãŒã¯ãããŸããïŒ æ°žä¹
çãªãã§ã€ã¹ãã£ã©ãŒããããã©ããã¯ãç§ã®æ£è
ã®å€ããå°ãã質åã§ããéåžžãç§ã®çãã¯ããŒã§ãã ããããããªã¥ãŒã æå€±ãå埩ãããããã°ããªã©ã®ç®èã®ããŒã¿ã«å¯ŸåŠãããããããã«ãé·æçã«æ°žä¹
çãªãã£ã©ãŒãå¿
èŠãšãã人ãããŸãããããã¯æè¡ãã¹ããã€ã泚å°ã§åãé€ãã®ãé£ããå ŽåããããŸãã ãã 1 ã€ã®æžå¿µã¯ã泚å°éšäœã«çºçããå¯èœæ§ããã硬ãå¡ã§ããèèœè
«ãçºçãããªã¹ã¯ã§ããããã¯ãé¡ãç®ã®äžéšã«è¡æ¶²ãäŸçµŠããåèã«æ°žä¹
å
å¡«å€ã泚å
¥ãããå Žåã«çºçããå¯èœæ§ããããŸãã é¡ã®ããã«å¯Ÿããé·æçãªè§£æ±ºçãæ¢ããŠãã人ã«ã¯ããã¢ã«ãã³é
žãªã©ã®äžæçãªãã£ã©ãŒãããé·æã¡ãããããª-L-ä¹³é
žãããªã¡ã¿ã¯ãªã«é
žã¡ãã« (PMMA) ãªã©ã®åæ°žä¹
çãªãã£ã©ãŒããå§ãããŸãããããã®ãã£ã©ãŒã¯ FDA ã®æ¿èªãåããŠãããå®å
šã«äœ¿çšã§ããŸãããŸããæ·±ãã»ãããç·ã®æ²»çãã»ãããç·ã®ä¿®æ£ãèãåã®å¢åŒ·ã«ã广çã§ããæ²»çéšäœã«å¿ããŠããããã®ãã£ã©ãŒã¯ 12 ãæãã 5 å¹Žä»¥äžæç¶ããããšãæåŸ
ã§ããŸãã ãã£ã©ãŒãæ©èãããšã©ããªããŸãã? ç®èå
å¡«å€ã¯ãé¡ã®çŸçããŒãºã«å¿ããããšèããŠããæ£è
ã«ãšã£ãŠçŽ æŽãããéžæè¢ãšãªããŸãããããå°ããã軜æžããã ãã§ãªããèåããç®èã®éãå¢ãããŠè¥ã
ããããããšãã§ããŸãã äžéšã®ãã£ã©ãŒã¯ãäœå
ã®ã³ã©ãŒã²ã³çæãå¢å ãããããã«èšèšãããŠããããã£ã©ãŒãæ¶ããåŸãé·æéã«ããã£ãŠå€èгã«ãã©ã¹ã®å¹æãããããå¯èœæ§ããããŸããããã¯ãèã®åŒŸåæ§ãšæ°Žåè£çµŠãæ¹åããããããã®ä»ã®å¹Žéœ¢ã®å
åã軜æžããããšãã§ããããã§ãã ããããå€ãã®æ£è
ããã¯ãã£ã©ãŒæ²»çåŸã«ç®èã®ããã¿ãæ®ãã®ã§ã¯ãªãããšå¿é
ããŠããŸããã»ãšãã©ã®ããŒãã«ãã£ã©ãŒã¯ç®èã䌞ã°ããããããŸãããã¯ããªããããããã¯éåžžåé¡ã«ã¯ãªããŸããããããããã£ã©ãŒãæ¶ãå§ãããšç®èã¯å埩ããŠå
ã®ç¶æ
ã«æ»ããŸãã äžéšã®æ£è
ã¯ããã£ã©ãŒã«ãã£ãŠèèœè
«ãçºçããã®ã§ã¯ãªãããšå¿é
ããŠããŸããããã¯ããã®å¯äœçšãå®è³ªçã«ãªãé«å質ã®ãã¢ã«ãã³é
žãã£ã©ãŒã«ã¯åœãŠã¯ãŸããŸããã ãã£ã©ãŒã¯ã©ããããæç¶ããŸãã? ãã§ã€ã·ã£ã«ãã£ã©ãŒã®æç¶æéã¯ããã£ã©ãŒã®çš®é¡ãé
åãäœã®ä»£è¬é床ãªã©ãããã€ãã®èŠå ã«ãã£ãŠç°ãªããŸãããã ãããããã€ããŒã®æšå¥šã«åŸããèªåèªèº«ã®ã±ã¢ã«ååæ³šæããã°ãå¹æã¯æ°å¹Žéç¶ãããšãæåŸ
ã§ããŸãã æãäžè¬çãªã¿ã€ãã®ãã§ã€ã¹ ãã£ã©ãŒã¯ãã¢ã«ãã³é
ž (HA) ãã£ã©ãŒã§ãçåè§£æ§ã²ã«ããäœãããŠããŸãããããã®è£œåã¯ãæ²»çéšäœãäœã®ä»£è¬é床ã«å¿ããŠãéåžž 6 ïœ...
ããªããªãã·ãªããã¯ã¬ãªãã (PDRN) ãšã¯äœã§ãã?
ããªããªãã·ãªããã¯ã¬ãªãã (PDRN) ã¯ãããŸããŸãªçç¶ã«ãããç®èã®åçãšåµå·æ²»çãå©ããããã«äœ¿çšãããŠãã DNA ç±æ¥ã®è¬å€ã§ãã 50ïœ2000å¡©åºå¯Ÿãéç¶ã«çµåããããªãã·ãªããã¯ã¬ãªããããªããŒã§æ§æãããŠããŸãã PDRN 㯠in vitro ã§çްèã®å¢æ®ãå¢å ãããããšã瀺ãããŠãããããç®èåçå€ãšããŠããå©çšãããŸããç³å°¿ç
ãé床ã®ç«å·ãªã©ãåµå·æ²»çãæãªãããŠããç¹å®ã®çç¶ã«ã广çã§ãã ç®èã®åç PDRN ã¯ãçµç¹ä¿®åŸ©ãåºæ¿ããççã軜æžããæ°ãã现èã®æé·ãä¿é²ãã广çãªç®è泚å°å€ã§ããã³ã©ãŒã²ã³ãHAãšã¯ç°ãªããPDRNã¯ç®èããªã¢ãç Žå£ããããšãªããå°ãããç¢çã®å€èŠ³ãæ¹åããåãããããŸãã PDRN ã¯äººéã®ç®èãšã®çäœé©åæ§ã«åªããŠãããã»ãšãã©ã®è¢«éšè
ã«ãšã£ãŠå®å
šã«äœ¿çšã§ããŸãããŸããèµ€ã¿ãéæçãæ¥å
ã§ãã¡ãŒãžãåããèãã·ããäžåäžãªèã®è²èª¿ã軜æžããã®ã«ã广çã§ãã ããã«ãPDRN ã¯ã³ã©ãŒã²ã³ãšãšã©ã¹ãã³ã®çæãå¢å ãããŸããããã«ãããããããªã®ããè¥ã
ããèãåŸãããŸãã ç®èã®åçã¯èåã®å
åãé²ãããã«äžå¯æ¬ ã§ãã PDRN ã¯ãåµå·æ²»çã®ããã»ã¹ãã¹ããŒãã¢ããããããã«ã䜿çšã§ããŸããããã«ãããç³å°¿ç
æ§è¶³æœ°çãç«å·ãå·è·¡ã®å¹æçãªæ²»çæ³ãšãªããŸãã åµå·æ²»ç 3 ãæä»¥å
ã«æ²»ããªãå·ã¯äººå£ã® 2% ã眹æ£ããäžè¬çãªåé¡ã§ãããæ²»çã«ã¯å¹Žé 30 åãã«ä»¥äžã®è²»çšãããããŸããè¿
éãªåµå·æ²»çã¯ãå
¥é¢æéãççž®ãããªãããªããŒã·ã§ã³ã®ææãåäžãããã®ã«åœ¹ç«ã¡ãŸãã PDRN (Placentex...
ãããªãã¹æ¯çŽ ãšã¯äœã§ãã?
ãããªãã¹æ¯çŽ ã¯ããããªãã¹èã®èåã«ãã£ãŠç£çãããŸããããã¯ãé£ã¹ç©ãå·ã«ååšããå¯èœæ§ãããèŽåœçãªç¥çµæ¯ã§ãã ãããªãã¹æ¯çŽ ãçèã«æ³šå°ããŠçèã麻çºãããŸããéŠã®ãããããéå°ãªçºæ±ãèè±ã®åé¡ã®æ²»çã«ã䜿çšãããŸãããŸããç®ã®äžã®ã¯ãã軜æžããå°ããããããæ¹åããããšãã§ããŸãã ãããªãã¹æ¯çŽ ãšã¯äœã§ãã? ãããªãã¹æ¯çŽ ã¯ããããªãã¹çã®åå ãšãªããããªãã¹èã«ãã£ãŠç£çãããç¥çµæ¯ã§ããç¥çµçµæ«ããã®ç¥çµäŒéç©è³ªã¢ã»ãã«ã³ãªã³ã®æŸåºãé»å®³ããçè麻çºãåŒãèµ·ãããŸãã ãŸãããããããç®ã®ããããïŒçŒçŒããããïŒãéŠã®æçž®ãçé çãéæŽ»åèè±ã®æ²»çã«ã䜿çšãããŸãã ãããªãã¹æ¯çŽ ã®æ³šå°ã¯ããã§ã€ã¹ã©ã€ã³ãã·ã¯ãæ¹åããå®å
šãã€å¹æçãªæ¹æ³ã§ãããããªãã¹æ¯çŽ ã®å¹æã¯æ³šå°åŸçŽ 3 ïœ 10 æ¥ããããæç¶ââã¯çŽ 3 ïœ 4 ãæéç¶ããŸãã ãããªãã¹æ¯çŽ ã®æ³šå°ã¯éèŠãªã¹ãã«ã§ãããè§£ååŠçæ§é ãšæè¡ã«ã€ããŠã®æ·±ãçè§£ãå¿
èŠã§ããæ³šå°ã誀ããšãèåšãç¥çµã®æå·ã«ã€ãªãã£ãããééã£ãçèã®è¡°åŒ±ãåŒãèµ·ããããããå¯èœæ§ããããŸãããã®ãããçŸå®¹åŠçœ®ãè¡ãåã«ãæ£è
ã®ç
æŽã培åºçã«èãããšãäžå¯æ¬ ãšãªã£ãŠããŸãã ãããªãã¹æ¯çŽ æ³šå° ãããªãã¹æ¯çŽ æ³šå°ã¯ãåäŸãå代ã®è¥è
ãæäººã®çèã®ããããã«äœ¿çšãããŸãããã®æ²»çæ³ã¯ãççž®ã®åå ãšãªãçèãå¶åŸ¡ããéåžžã«å®å
šã§å¹æçãªæ¹æ³ã§ãã æ³šå°ã¯çèã®ããããã®éç床ã軜æžããçæŽ»ã®è³ªãåäžãããã®ã«åœ¹ç«ã¡ãŸãããã®æ³šå°ã¯ãç¥çµçµæ«ããã®ç¥çµäŒéç©è³ªã¢ã»ãã«ã³ãªã³ã®æŸåºããããã¯ããããšã«ãã£ãŠäœçšããŸãã ç®èãŸãã¯çèã«çŽæ¥æ³šå°ãããŸããåé¡ã®éç床ã軜æžããã«ã¯ãè€æ°åã®æ³šå°ãå¿
èŠã«ãªãå ŽåããããŸãã ãããªãã¹æ¯çŽ ã®å¯äœçš ãããªãã¹æ¯çŽ ã¯ãççž®ã®æ²»çã«äœ¿çšã§ããè¬ã§ããããã¯è³æ§éº»çºã®åäŸã«ããèŠãããåé¡ã§ãåããå°é£ã«ãªãããšããããŸããçµå£è¬ã泚å°è¬ã¯ãççž®ã軜æžããå¯åæ§ãé«ããã®ã«åœ¹ç«ã¡ãŸãã ãã ãããã®è¬ã«ã¯ããã€ãã®å¯äœçšããããŸããäžéšã®å¯äœçšã¯è»œåºŠã§ãèªç¶ã«ããŸãã¯æéã®çµéãšãšãã«æ¶ããå ŽåããããŸãã äžéšã®å¯äœçšã¯æ³šå°ã«é¢é£ããŠãããæ³šå°éšäœã®çã¿ãè
«ãããããªã©ãå«ãŸããŸãããããã®å¯äœçšã¯éåžžæ°æ¥éç¶ããèªç¶ã«æ¶ããŸãã é çãããããå¯äœçšã§ããè»œåºŠã§æ°æ¥ä»¥å
ã«æ²»ãŸãå Žåãããã°ãéåºŠã§æ°é±éç¶ãå ŽåããããŸããããã¯ãéãæ·±éšã®çèè¡è
«ã«åœãã£ãããæ³šå°èªäœã®ã¹ãã¬ã¹ãåå ã§ããå¯èœæ§ããããŸãããŸããç¹å®ã®ç®ã®åé¡ (ç·å
é) ãå¿èç
ãªã©ã®æ£è
ã®ç
æŽã«é¢é£ããŠããå¯èœæ§ããããŸãã ãããªãã¹æ¯çŽ ã¯ã¯ãã³ ãããªãã¹çç¥çµæ¯ã®ã¯ã¯ãã³ãéçºãããŠããŸããç®æšã¯ããããã®æ¯çŽ ãžã®æé²ããæ£è
ãä¿è·ããå
ç«å¿çãçæãããããªãã¹çãäºé²ããæ²»çã®å¿
èŠæ§ãæžããããšã§ãã ã¯ã¯ãã³ãéçºããããã«ãç ç©¶è
ãã¯é£äžæ¯ã®åå ãšãªãæ¯çŽ ãç£çãããããªãã¹èã®ç ç©¶ãè¡ã£ãŠããããã®æ¯çŽ ã¯ç¥çµäŒéã劚害ããç¥çµäŒéç©è³ªã¢ã»ãã«ã³ãªã³ã®æŸåºããããã¯ããŸãã ãã®çµæãçåäœäžã麻çºãèµ·ãããŸãããã®æ¯çŽ ã¯ããããªãã¹èãé
žæ§æ¡ä»¶ã§å¢æ®ãããšãã«çæãããŸãã...
